Literature DB >> 27036062

How Trypanosoma cruzi deals with oxidative stress: Antioxidant defence and DNA repair pathways.

Alice Machado-Silva1, Paula Gonçalves Cerqueira2, Viviane Grazielle-Silva2, Fernanda Ramos Gadelha3, Eduardo de Figueiredo Peloso3, Santuza Maria Ribeiro Teixeira2, Carlos Renato Machado4.   

Abstract

Trypanosoma cruzi, the causative agent of Chagas disease, is an obligatory intracellular parasite with a digenetic life cycle. Due to the variety of host environments, it faces several sources of oxidative stress. In addition to reactive oxygen species (ROS) produced by its own metabolism, T. cruzi must deal with high ROS levels generated as part of the host's immune responses. Hence, the conclusion that T. cruzi has limited ability to deal with ROS (based on the lack of a few enzymes involved with oxidative stress responses) seems somewhat paradoxical. Actually, to withstand such variable sources of oxidative stress, T. cruzi has developed complex defence mechanisms. This includes ROS detoxification pathways that are distinct from the ones in the mammalian host, DNA repair pathways and specialized polymerases, which not only protect its genome from the resulting oxidative damage but also contribute to the generation of genetic diversity within the parasite population. Recent studies on T. cruzi's DNA repair pathways as mismatch repair (MMR) and GO system suggested that, besides a role associated with DNA repair, some proteins of these pathways may also be involved in signalling oxidative damage. Recent data also suggested that an oxidative environment might be beneficial for parasite survival within the host cell as it contributes to iron mobilization from the host's intracellular storages. Besides contributing to the understanding of basic aspects of T. cruzi biology, these studies are highly relevant since oxidative stress pathways are part of the poorly understood mechanisms behind the mode of action of drugs currently used against this parasite. By unveiling new peculiar aspects of T. cruzi biology, emerging data on DNA repair pathways and other antioxidant defences from this parasite have revealed potential new targets for a much needed boost in drug development efforts towards a better treatment for Chagas disease.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  DNA repair; Genetic diversity; Oxidative stress; Trypanosoma cruzi

Mesh:

Substances:

Year:  2015        PMID: 27036062     DOI: 10.1016/j.mrrev.2015.12.003

Source DB:  PubMed          Journal:  Mutat Res Rev Mutat Res        ISSN: 1383-5742            Impact factor:   5.657


  19 in total

1.  Benefits of Ascorbic Acid in Association with Low-Dose Benznidazole in Treatment of Chagas Disease.

Authors:  Maiara Voltarelli Providello; Zumira Aparecida Carneiro; Gisele Bulhões Portapilla; Gabriel Tavares do Vale; Ricardo Souza Camargo; Carlos Renato Tirapelli; Sérgio de Albuquerque
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

2.  Ultrastructural and physiological changes induced by different stress conditions on the human parasite Trypanosoma cruzi.

Authors:  Deyanira Pérez-Morales; Karla Daniela Rodríguez Hernández; Ignacio Martínez; Lourdes Teresa Agredano-Moreno; Luis Felipe Jiménez-García; Bertha Espinoza
Journal:  Cell Stress Chaperones       Date:  2016-10-06       Impact factor: 3.667

3.  A Comparative In Silico Study of the Antioxidant Defense Gene Repertoire of Distinct Lifestyle Trypanosomatid Species.

Authors:  Ingrid Thaís Beltrame-Botelho; Carlos Talavera-López; Björn Andersson; Edmundo Carlos Grisard; Patricia Hermes Stoco
Journal:  Evol Bioinform Online       Date:  2016-11-07       Impact factor: 1.625

4.  The Correlation between Chemical Structures and Antioxidant, Prooxidant, and Antitrypanosomatid Properties of Flavonoids.

Authors:  João Luiz Baldim; Bianca Gonçalves Vasconcelos de Alcântara; Olívia da Silva Domingos; Marisi Gomes Soares; Ivo Santana Caldas; Rômulo Dias Novaes; Tiago Branquinho Oliveira; João Henrique Ghilardi Lago; Daniela Aparecida Chagas-Paula
Journal:  Oxid Med Cell Longev       Date:  2017-07-02       Impact factor: 6.543

5.  Canine Macrophage DH82 Cell Line As a Model to Study Susceptibility to Trypanosoma cruzi Infection.

Authors:  Pedro Henrique Braz Mendonça; Raphael Francisco Dutra Barbosa da Rocha; Julliane Brito de Braz Moraes; Isabel Ferreira LaRocque-de-Freitas; Jorgete Logullo; Alexandre Morrot; Marise Pinheiro Nunes; Celio Geraldo Freire-de-Lima; Debora Decote-Ricardo
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

Review 6.  ROS and Trypanosoma cruzi: Fuel to infection, poison to the heart.

Authors:  Claudia N Paiva; Emiliano Medei; Marcelo T Bozza
Journal:  PLoS Pathog       Date:  2018-04-19       Impact factor: 6.823

7.  Assessment of genetic mutation frequency induced by oxidative stress in Trypanosoma cruzi.

Authors:  Carolina Furtado Torres-Silva; Bruno Marçal Repolês; Hugo Oliveira Ornelas; Andréa Mara Macedo; Glória Regina Franco; Sérgio Danilo Junho Pena; Erich Birelli Tahara; Carlos Renato Machado
Journal:  Genet Mol Biol       Date:  2018-06-11       Impact factor: 1.771

8.  Role of Trypanosoma cruzi nucleoside diphosphate kinase 1 in DNA damage responses.

Authors:  Chantal Reigada; Melisa Sayé; Fabio Di Girolamo; Edward A Valera-Vera; Claudio A Pereira; Mariana R Miranda
Journal:  Mem Inst Oswaldo Cruz       Date:  2020-07-15       Impact factor: 2.743

Review 9.  Challenges in Chagas Disease Drug Development.

Authors:  Amanda F Francisco; Shiromani Jayawardhana; Francisco Olmo; Michael D Lewis; Shane R Wilkinson; Martin C Taylor; John M Kelly
Journal:  Molecules       Date:  2020-06-17       Impact factor: 4.411

10.  Trypanosoma brucei and Trypanosoma cruzi DNA Mismatch Repair Proteins Act Differently in the Response to DNA Damage Caused by Oxidative Stress.

Authors:  Viviane Grazielle-Silva; Tehseen Fatima Zeb; Richard Burchmore; Carlos Renato Machado; Richard McCulloch; Santuza M R Teixeira
Journal:  Front Cell Infect Microbiol       Date:  2020-04-16       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.